Delfi Ltd
SGX:P34
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Delfi Ltd
Cash & Cash Equivalents
Delfi Ltd
Cash & Cash Equivalents Peer Comparison
F99
MV4
UD2
Q01
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
D
|
Delfi Ltd
SGX:P34
|
Cash & Cash Equivalents
$59.4m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-11%
|
|
|
Fraser and Neave Ltd
SGX:F99
|
Cash & Cash Equivalents
S$473.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-6%
|
|
|
Mewah International Inc
SGX:MV4
|
Cash & Cash Equivalents
$131.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
22%
|
CAGR 10-Years
8%
|
|
|
Japfa Ltd
SGX:UD2
|
Cash & Cash Equivalents
$189.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
|
QAF Ltd
SGX:Q01
|
Cash & Cash Equivalents
S$215.7m
|
CAGR 3-Years
38%
|
CAGR 5-Years
29%
|
CAGR 10-Years
10%
|
|
F
|
Food Empire Holdings Ltd
SGX:F03
|
Cash & Cash Equivalents
$131.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
See Also
What is Delfi Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
59.4m
USD
Based on the financial report for Dec 31, 2023, Delfi Ltd's Cash & Cash Equivalents amounts to 59.4m USD.
What is Delfi Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-11%
Over the last year, the Cash & Cash Equivalents growth was 214%. The average annual Cash & Cash Equivalents growth rates for Delfi Ltd have been 43% over the past three years , -2% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
